Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Sep 26,2016
Cell Division the Outcome of an Adversarial Process
Two mutually antagonistic protein complexes have been found to duel on the precipice of cell division. Whichever one prevails determines whether the cell remains in the G1 phase (where the focus is on growth) or enters the S phase (where the focus is on chromosome duplication and separation). It has long been known that oneRead more
More
Sep 26,2016
Fluorescent In Situ Hybridization (Fish) Services
Medicilon offers a full line of Fluorescence in situ Hybridization (FISH) services, from standardized testing of validated assays to custom development of new assays. Drawing on many years of experience and in-depth knowledge, we guarantee that you will get the best FISH services from us for the ultimate success of your scientific research. FISH, alsoRead more
More
Fluorescent In Situ Hybridization (Fish) Services
Sep 23,2016
Ion Channel Screening Services
Ion Channel Screening Service Medicilon provides a wide range of ion channel assays to quickly and accurately provide results for drug discovery and development research worldwide. We offer ion channel screening services on a variety of different high quality electrophysiology platforms. These services include: Compound Screening  Our screening compound system allows chemists and compound managersRead more
More
Ion Channel Screening Services
Sep 23,2016
Unpriming Bacterial Pumps to Block Antibiotic Resistance
    When a bacterial machine called the efflux pump is in working order, it expels antibiotics, contributing to antibiotic resistance. The pump, however, cannot work if it lacks all of its molecule-sized parts. Keeping these parts out of stock, then, is a promising strategy in preserving the effectiveness of antibiotics that qualify as "last line ofRead more
More
Unpriming Bacterial Pumps to Block Antibiotic Resistance
Sep 23,2016
New Protein Target Offers Hope for Crohn Sufferers
    Researchers from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identified a promising new target for future drugs to treat inflammatory bowel disease (IBD). Their study ("Control of Paneth Cell Fate, Intestinal Inflammation, and Tumorigenesis by PKCλ/ι”), published in Cell Reports, also indicates that another protein, protein kinase C (PKC) λ/ι, may serve as aRead more
More
New Protein Target Offers Hope for Crohn Sufferers
Sep 22,2016
Immunotherapy Boosted by Discovery of Molecular Switch
Exploiting the body's immune system to fight progressive pathological conditions such as cancer, Crohn's, and Alzheimer's is the basis for novel immunotherapy compounds that are beginning to take the drug market by storm. While various immunotherapy regimens have met with excellent results, not every patient has had an efficacious response.
More
Immunotherapy Boosted by Discovery of Molecular Switch
Sep 22,2016
Novel Cancer Therapy Attacks Fatty Acid Synthesis in Cells
Scientists know that cells create their own fat molecules to build their plasma membranes and other critical structures. Now, researchers at the Salk Institute, along with academic and industry collaborators, have described a method ("Inhibition of Acetyl-CoA Carboxylase Suppresses Fatty Acid Synthesis and Tumor Growth of Non-Small-Cell Lung Cancer in Preclinical Models") in Nature Medicine
More
Novel Cancer Therapy Attacks Fatty Acid Synthesis in Cells
Sep 22,2016
Medicilon's Yeast Two Hybrid Services
The yeast "two hybrid” or "interaction trap” assay, is a technique used to study protein-protein interactions, which are critical in virtually all cellular processes. The study of protein-protein interactions can be divided into three major parts: • Identification of binding proteins • Characterization of known interactions • Potential to manipulate such interactions This technology isRead more
More
Medicilon's Yeast Two Hybrid Services
Sep 21,2016
Pathogenic Gut Microbes Flourish in Wake of Tissue Repair Response
    In an effort to understand the mechanisms governing pathogenic gut bacteria better, researchers at the University of California Davis, School of Medicine inquired why some food-borne bacteria cause severe illness. In the results from their recently published study, the investigators describe how pathogens in the intestinal tract cause harm by benefiting from immune system responsesRead more
More
Sep 21,2016
Snail Insulin Faster Than Human Insulin
    Slow and steady may not always win the race, not when an insulin injection is needed to control diabetes. Although fast-acting synthetic versions of human insulin have been available since 1996, they may not be fast enough, taking 15 to 30 minutes to become effective. An even faster version of insulin, however, may be gainingRead more
More
Snail Insulin Faster Than Human Insulin
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->